Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Remifentanil for Sedation in Urogynecological Surgery
NCT03883347Phase 3Unknown
- Sponsor
- National and Kapodistrian University of Athens
- Start
- Mar 2019
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in urogynecologic disorders, sponsored by National and Kapodistrian University of Athens. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
urogynecologic disorders
Beyond the preview
Go deeper on NCT03883347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03883347.